Global Equity Income Closed-End Portfolio, Series 90
Ticker Symbol: FTYWAX
22 Holdings (As of Day of Deposit) |
Ticker |
Company Name |
Initial
Weight |
Price* |
Specialized Equity Funds (43%) |
AWP |
abrdn Global Premier Properties Fund |
5.00% |
$4.30 |
EOD |
Allspring Global Dividend Opportunity Fund |
1.50% |
4.81 |
BGR |
BlackRock Energy and Resources Trust |
5.00% |
12.92 |
BGY |
BlackRock Enhanced International Dividend Trust |
6.50% |
5.49 |
BCX |
BlackRock Resources & Commodities Strategy Trust |
6.50% |
9.32 |
IGR |
CBRE Global Real Estate Income Fund |
4.00% |
5.77 |
UTF |
Cohen & Steers Infrastructure Fund, Inc. |
5.00% |
25.12 |
GNT |
GAMCO Natural Resources, Gold & Income Trust |
3.00% |
5.84 |
HEQ |
John Hancock Hedged Equity & Income Fund |
2.50% |
10.72 |
IAE |
Voya Asia Pacific High Dividend Equity Income Fund |
4.00% |
6.42 |
World Equity Funds (57%) |
IAF |
abrdn Australia Equity Fund, Inc. |
5.00% |
4.39 |
AEF |
abrdn Emerging Markets Equity Income Fund, Inc. |
6.00% |
5.39 |
AGD |
abrdn Global Dynamic Dividend Fund |
5.00% |
10.16 |
BOE |
BlackRock Enhanced Global Dividend Trust |
4.00% |
11.28 |
CHW |
Calamos Global Dynamic Income Fund |
1.50% |
6.90 |
ETG |
Eaton Vance Tax-Advantaged Global Dividend Income Fund |
5.00% |
18.58 |
ETO |
Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund |
5.00% |
25.40 |
ETW |
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund |
5.00% |
8.41 |
EXG |
Eaton Vance Tax-Managed Global Diversified Equity Income Fund |
5.00% |
8.29 |
LGI |
Lazard Global Total Return and Income Fund, Inc. |
5.00% |
16.74 |
IHD |
Voya Emerging Markets High Dividend Equity Fund |
6.50% |
5.41 |
IGD |
Voya Global Equity Dividend and Premium Opportunity Fund |
4.00% |
5.41 |
*As of the close of business on 10/31/24.
Market values are for reference only and are not indicative of your individual
cost basis.
Not FDIC Insured Not Bank Guaranteed May Lose Value |
Portfolio Summary |
Initial Date of Deposit |
11/1/2024 |
Initial Public Offering Price |
$10.00 per Unit |
Portfolio Ending Date |
11/2/2026 |
Historical 12-Month Distribution Rate of Trust Holdings:* |
8.07% |
Historical 12-Month Distribution Per Unit:* |
$0.8066 |
Cash
CUSIP |
30338U103 |
Reinvestment
CUSIP |
30338U111 |
Fee Account Cash CUSIP |
30338U129 |
Fee Account Reinvestment CUSIP |
30338U137 |
*There is no guarantee the issuers of the securities included in the trust will declare dividends or distributions
in the future. The historical 12-month distribution per unit and historical 12-month distribution rate of
the securities included in the trust are for illustrative purposes only and are not indicative of the trust’s
distribution or distribution rate. The historical 12-month distribution per unit is based on the weighted
average of the trailing 12-month distributions paid by the securities included in the portfolio. The historical
12-month distribution rate is calculated by dividing the historical 12-month distributions by the trust’s
offering price. The historical 12-month distribution and rate are reduced to account for the effects of fees
and expenses, which will be incurred when investing in a trust. Certain of the issuers may have reduced
their dividends or distributions over the prior 12 months. The distribution per unit and rate paid by the trust
may be higher or lower than the amount shown above due to certain factors that may include, but are not
limited to, a change in the dividends or distributions paid by issuers, actual expenses incurred, or the sale of
securities in the portfolio.
Fee Table (based on a $10 public offering
price per unit) |
|
Standard |
Fee/Wrap |
Deferred Sales Charge |
2.25% |
— |
Creation & Development Fee (C&D Fee) |
0.50% |
0.50% |
Maximum Sales Charge |
2.75% |
0.50% |
|
|
|
Estimated Organization Costs |
0.510% |
0.510% |
|
|
|
Operating Expenses |
0.218% |
0.218% |
Acquired Fund Fees and Expenses^ |
1.526% |
1.526% |
Estimated Annual Trust Operating Expenses |
1.744% |
1.744% |
^Although not actual trust operating expenses, the trust, and therefore unit holders, will indirectly bear
similar operating expenses of the funds in which the trust invests. These expenses are estimated and are
subject to change in the future.
The deferred sales charge will be deducted in three monthly installments commencing 2/20/25. When
the public offering price is less than or equal to $10.00 per unit, there will be no initial sales charge. If the
price exceeds $10.00 per unit, you will pay an initial sales charge. The C&D fee is a charge of $0.050 per unit
collected at the end of the initial offering period. If the price you pay exceeds $10.00 per unit, the C&D fee
will be less than 0.50%; if the price you pay is less than $10.00 per unit, the C&D fee will exceed 0.50%.
Estimated organization costs will be deducted from the assets of the trust at the end of the initial offering
period. Estimated organization costs and trust operating expenses are assessed on a fixed dollar amount per
unit basis which, as a percentage of average net assets, will vary over time. Actual expenses may be more or
less than the estimates. Please see “Fee Table” in the trust prospectus for additional information.
You should consider the portfolio's investment objectives, risks, and
charges and expenses carefully before investing. Contact your financial professional
or call First Trust Portfolios L.P. at 1.800.621.1675 to request a prospectus,
which contains this and other information about the portfolio. Read it carefully
before you invest.
Risk Considerations
An investment in this
unmanaged unit investment trust should be made with an
understanding of the risks associated with an investment in a
portfolio of closed-end funds.
Closed-end funds are subject to various risks, including management’s ability to meet the fund’s investment objective, and to manage the fund’s portfolio when the underlying securities are redeemed or sold, during periods of
market turmoil and as investors’ perceptions regarding the funds or their underlying investments change. Unlike open-end funds, which trade at prices based on a current determination of the fund’s net asset value, closed-end
funds frequently trade at a discount to their net asset value in the secondary market.
Common stocks are subject to risks such as an economic recession and the possible deterioration of either the financial condition of the issuers of the equity securities or the general condition of the stock market.
Options are subject to various risks including that their value may be adversely affected if the market for the option becomes less liquid or smaller. In addition, options will be affected by changes in the value and dividend rates of
the stock subject to the option, an increase in interest rates, a change in the actual and perceived volatility of the stock market and the common stock and the remaining time to expiration.
Securities of non-U.S. issuers are subject to additional risks, including currency fluctuations, political risks, withholding, the lack of adequate financial information, and exchange control restrictions impacting non-U.S. issuers.
Risks associated with investing in non-U.S. securities may be more pronounced in emerging and developing markets where the securities markets are substantially smaller, less developed, less liquid, less regulated, and more
volatile than the U.S. and developed non-U.S. markets.
As the use of Internet technology has become more prevalent in
the course of business, the trust has become more susceptible to
potential operational risks through breaches in cybersecurity.
Ongoing armed conflicts between Russia and Ukraine in Europe and among Israel, Hamas and other militant groups in the Middle East have caused and could continue to cause significant market disruptions and volatility
within the markets in Russia, Europe, the Middle East and the United States. The hostilities and sanctions resulting from those hostilities could have a significant impact on certain investments as well as performance.
The ongoing effects of the COVID-19 global pandemic, or the potential impacts of any future public health crisis, may cause significant volatility and uncertainty in global financial markets. While vaccines have been developed, there is no guarantee that vaccines will be effective against future variants of the disease.
The value of the securities held by the trust may be subject to
steep declines or increased volatility due to changes in
performance or perception of the issuers.
It is important to note that an investment can be made in the
underlying funds directly rather than through the trust. These
direct investments can be made without paying the trust’s sales
charge, operating expenses and organizational costs.
This UIT is a buy and hold strategy and investors should consider
their ability to hold the trust until maturity. There may be tax
consequences unless units are purchased in an IRA or other
qualified plan.
For a discussion of additional risks of investing in the trust see
the “Risk Factors” section of the prospectus.